{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:32:40Z","timestamp":1779323560921,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00520-015-2978-0","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T23:10:14Z","timestamp":1444173014000},"page":"1789-1793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0539-2379","authenticated-orcid":false,"given":"Trevor","family":"McKibbin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conor E.","family":"Steuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taofeek K.","family":"Owonikoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadlo R.","family":"Khuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong M.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil F.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"key":"2978_CR1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","volume":"21","author":"DJ Adelstein","year":"2003","unstructured":"Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol : Off J Am Soc Clin Oncol 21:92\u201398","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"2978_CR2","first-page":"31","volume":"66","author":"M Al-Sarraf","year":"1982","unstructured":"Al-Sarraf M, Fletcher W, Oishi N, Pugh R, Hewlett JS, Balducci L, McCracken J, Padilla F (1982) Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. Cancer Treat Rep 66:31\u201335","journal-title":"Cancer Treat Rep"},{"key":"2978_CR3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","volume":"23","author":"I Arany","year":"2003","unstructured":"Arany I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460\u2013464","journal-title":"Semin Nephrol"},{"key":"2978_CR4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M, European Organization for R, Treatment of Cancer T (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945\u20131952","journal-title":"N Engl J Med"},{"key":"2978_CR5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-95-5-628","volume":"95","author":"JD Blachley","year":"1981","unstructured":"Blachley JD, Hill JB (1981) Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 95:628\u2013632","journal-title":"Ann Intern Med"},{"key":"2978_CR6","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.ejca.2008.08.005","volume":"44","author":"L Bodnar","year":"2008","unstructured":"Bodnar L, Wcislo G, Gasowska-Bodnar A, Synowiec A, Szarlej-Wcislo K, Szczylik C (2008) Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study. Eur J Cancer 44:2608\u20132614","journal-title":"Eur J Cancer"},{"key":"2978_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephronology 16:31\u201341","journal-title":"Nephronology"},{"key":"2978_CR8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK, Radiation Therapy Oncology Group I (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937\u20131944","journal-title":"N Engl J Med"},{"key":"2978_CR9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","volume":"86","author":"NA Santos dos","year":"2012","unstructured":"dos Santos NA, Carvalho Rodrigues MA, Martins NM, dos Santos AC (2012) Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol 86:1233\u20131250","journal-title":"Arch Toxicol"},{"key":"2978_CR10","first-page":"903","volume":"61","author":"V Launay-Vacher","year":"2008","unstructured":"Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M, European Society of Clinical Pharmacy Special Interest Group on Cancer C (2008) Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Chemo Pharmacol 61:903\u2013909","journal-title":"Chemo Pharmacol"},{"key":"2978_CR11","unstructured":"Mohamed A, Schrapp K, Owonikoko TK, Chen Z, Pakkala S, Pillai R, Wadsworth T, Higgins K, Ramalingam SS, Beitler JJ, Shin DM, Khuri FR, Behera M, Saba NF (2015) Concurrent chemoradiation using weekly versus tri-weekly cisplatin in locally advanced squamous cell cancer of the head and neck: a comparative analysis J Clin Oncol : Off J Am Soc Clin Oncol 33: abstr. 6055"},{"key":"2978_CR12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1177\/1060028014533303","volume":"48","author":"KP Morgan","year":"2014","unstructured":"Morgan KP, Snavely AC, Wind LS, Buie LW, Grilley-Olson J, Walko CM, Weiss J (2014) Rates of renal toxicity in cancer patients receiving cisplatin with and without mannitol. Ann Pharmacother 48:863\u2013869","journal-title":"Ann Pharmacother"},{"key":"2978_CR13","first-page":"562","volume":"4","author":"K Muraki","year":"2012","unstructured":"Muraki K, Koyama R, Honma Y, Yagishita S, Shukuya T, Ohashi R, Takahashi F, Kido K, Iwakami S, Sasaki S, Iwase A, Takahashi K (2012) Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer. J Thorac Dis 4:562\u2013568","journal-title":"J Thorac Dis"},{"key":"2978_CR14","first-page":"55","volume":"12","author":"GS Oh","year":"2014","unstructured":"Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, So HS (2014) Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies electrolyte & blood pressure. E & BP 12:55\u201365","journal-title":"E & BP"},{"key":"2978_CR15","first-page":"73","volume":"65","author":"S Ostrow","year":"1981","unstructured":"Ostrow S, Egorin MJ, Hahn D, Markus S, Aisner J, Chang P, LeRoy A, Bachur NR, Wiernik PH (1981) High-dose cisplatin therapy using mannitol versus furosemide diuresis: comparative pharmacokinetics and toxicity. Cancer Treat Rep 65:73\u201378","journal-title":"Cancer Treat Rep"},{"key":"2978_CR16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/0284186X.2012.731524","volume":"52","author":"S Ottosson","year":"2013","unstructured":"Ottosson S, Zackrisson B, Kjellen E, Nilsson P, Laurell G (2013) Weight loss in patients with head and neck cancer during and after conventional and accelerated radiotherapy. Acta Oncol 52:711\u2013718","journal-title":"Acta Oncol"},{"key":"2978_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-003-0620-1","volume":"52","author":"JT Santoso","year":"2003","unstructured":"Santoso JT, Lucci JA 3rd, Coleman RL, Schafer I, Hannigan EV (2003) Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial. Cancer Chemother Pharmacol 52:13\u201318","journal-title":"Cancer Chemother Pharmacol"},{"key":"2978_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","volume":"334","author":"X Yao","year":"2007","unstructured":"Yao X, Panichpisal K, Kurtzman N, Nugent K (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115\u2013124","journal-title":"Am J Med Sci"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2978-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2978-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:09:46Z","timestamp":1559081386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2978"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2978-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}